IONTOX builds human-relevant testing strategies for predicting toxicity without relying solely on conventional animal studies. Its laboratories use 2D and 3D cell systems, organotypic tissues, microphysiological models, high-content imaging, and computational approaches to investigate organ-specific and systemic effects. Programs can be designed around liver, kidney, cardiac, neurological, pulmonary, or developmental risk, helping teams select safer candidates and understand mechanisms of toxicity earlier.

